124 related articles for article (PubMed ID: 488666)
1. Effects of etofibrate, clofibrate and nicotinic acid on lipid metabolism in hyperlipidemic rats.
Priego JG; Maroto ML; Piña M; Catalán RE
Gen Pharmacol; 1979; 10(4):315-8. PubMed ID: 488666
[No Abstract] [Full Text] [Related]
2. Effects of etofibrate, clofibrate and nicotinic acid on lipid metabolism in normolipemic rats.
Priego JG; Maroto ML; Piña M; Catalan RE
Gen Pharmacol; 1979; 10(3):215-9. PubMed ID: 467961
[No Abstract] [Full Text] [Related]
3. [Action of etofibrate, clofibrate and nicotinic acid on the metabolism of lipids in normolipemic rats. Short term effects and method of action].
Priego JG; Piña M; Armijo M; Sunkel C; Maroto ML
Arch Farmacol Toxicol; 1979 Apr; 5(1):29-42. PubMed ID: 38756
[No Abstract] [Full Text] [Related]
4. [Effect of ethofibrate [2-(nicotinoyloxy)ethyl-p-chlorophenoxyisobutyrate] lipid metabolism. II. Effects on the incorporation of various isotopic precursors in rat liver].
Priego JG; Maroto ML; Piña M; Catalán RE
Arch Farmacol Toxicol; 1978 Apr; 4(1):28-30. PubMed ID: 697397
[No Abstract] [Full Text] [Related]
5. [Etofibrate and clofibrate in a double-blind trial on patients with raised serum-lipid levels (author's transl)].
Kaffarnik H; Schneider J; Haase W
Dtsch Med Wochenschr; 1975 Nov; 100(48):2486-8. PubMed ID: 1104303
[TBL] [Abstract][Full Text] [Related]
6. Effects of etofibrate, clofibrate and nicotinic acid on the cyclic AMP-protein kinase system in rats.
Catalán RE; Aragones MD; Martinez AM; Armijo M; Priego JG
Gen Pharmacol; 1979; 10(6):455-8. PubMed ID: 230120
[No Abstract] [Full Text] [Related]
7. [Effect of ethofibrate [2-(nicotinoyloxy)ethyl-p-chlorophenoxyisobutyrate] on lipid metabolism. I. Effect on blood lipids in normal and hyperlipemic rats].
Maroto ML; Priego JG; Piña M; Catalán RE
Arch Farmacol Toxicol; 1978 Apr; 4(1):25-7. PubMed ID: 697396
[No Abstract] [Full Text] [Related]
8. [Lipid depression by etofibrate in a comparative study in rats with artificial hyperlipidemia].
Sterner W; Schultz A
Arzneimittelforschung; 1974 Dec; 24(12):1990-2. PubMed ID: 4480360
[No Abstract] [Full Text] [Related]
9. The mechanism of action of clofibrate and tetranicotinoylfructose (Bradilan) on the kinetics of plasma free fatty acid and triglyceride transport in type IV and type V hypertriglyceridaemia.
Kissebah AH; Adams PW; Harrigan P; Wynn V
Eur J Clin Invest; 1974 Jun; 4(3):163-74. PubMed ID: 4838694
[No Abstract] [Full Text] [Related]
10. Influence of Etofibrate on plasma fibrinogen and plasminogen concentrations in patients with different forms of primary hyperlipoproteinemia.
Spöttl F; Froschauer J
Atherosclerosis; 1976; 25(2-3):293-301. PubMed ID: 1008913
[TBL] [Abstract][Full Text] [Related]
11. Effects of etofibrate on platelet function: in vitro studies in human plasma.
Ortega MP; Sunkel C; Armijo M; Priego JG
Thromb Res; 1980 Aug; 19(3):409-16. PubMed ID: 7001672
[No Abstract] [Full Text] [Related]
12. [Hypolipemic agents].
Paoletti R; Fumagalli R; Sirtori R
Minerva Med; 1973 Apr; 64(24):1267-75. PubMed ID: 4707410
[No Abstract] [Full Text] [Related]
13. [Research regarding the action of a derivative of the clofibric acid series on lipid metabolism].
Filip M; Păduraru I; Hriscu A; Neacşu R; Dănilă G; Filip F
Rev Med Chir Soc Med Nat Iasi; 1987; 91(2):341-5. PubMed ID: 3685700
[No Abstract] [Full Text] [Related]
14. Pharmacokinetics and hypolipidemic activity of clofibrate-nicotinic acid combinations in rats.
Cayen MN; Robinson WT; Dubuc J; Dvornik D
Biochem Pharmacol; 1979 Apr; 28(7):1163-7. PubMed ID: 444274
[No Abstract] [Full Text] [Related]
15. Studies with etofibrate in the rat. Part I: Effects on glycerol, free fatty acid and triacylglycerol metabolism.
Herrera E; Lasunción MA; Castro M; Gómez-Coronado D; Martín A; Quack G
Biochim Biophys Acta; 1988 Nov; 963(1):42-52. PubMed ID: 3179329
[TBL] [Abstract][Full Text] [Related]
16. [Mechanism of action of drugs affecting lipid metabolism].
Rossini L
Minerva Med; 1975 Oct; 66(66):3458-68. PubMed ID: 1178137
[No Abstract] [Full Text] [Related]
17. Synthesis and antilipidemic properties of cis-7-chloro-3a, 8b-dihydro-3a-methylfuro[3,4-b]benzofuran-3(1H)-one, a tricyclic clofibrate related lactone having a structural resemblance to mevalonolactone.
Witiak DT; Kuwano E; Feller DR; Baldwin JR; Newman HA; Sankrappa SK
J Med Chem; 1976 Oct; 19(10):1214-20. PubMed ID: 994152
[TBL] [Abstract][Full Text] [Related]
18. Changes in the fatty acid composition of the plasma lipid esters during lipid-lowering treatment with diet, clofibrate and niceritrol. Reduction of the proportion of linoleate by clofibrate but not by niceritrol.
Vessby B; Lithell H; Gustafsson IB; Boberg J
Atherosclerosis; 1980 Jan; 35(1):51-65. PubMed ID: 6989377
[TBL] [Abstract][Full Text] [Related]
19. Effect of clofibrate on lipoprotein metabolism in hyperlipidemic rats.
Segal P; Roheim PS; Eder HA
J Clin Invest; 1972 Jul; 51(7):1632-8. PubMed ID: 4338117
[TBL] [Abstract][Full Text] [Related]
20. The effect of niceritrol (pentaerythritoltetranicotinate) and clofibrate upon hyperlipemia and atherosclerosis induced in rabbits by cholesterol-free semisynthetic diets.
Brattsand R
Atherosclerosis; 1974; 20(3):453-67. PubMed ID: 4373017
[No Abstract] [Full Text] [Related]
[Next] [New Search]
